Bio Key International (BKYI) Liabilities and Shareholders Equity (2010 - 2025)

Bio Key International's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $10.1 million for Q3 2025.

• In Q3 2025, Liabilities and Shareholders Equity rose 58.03% year-over-year to $10.1 million; the TTM figure through Sep 2025 stood at $40.4 million (up 103.32% YoY), while the FY2024 annual figure was $8.6 million, up 90.73% from the prior year.
• Liabilities and Shareholders Equity came in at $10.1 million for Q3 2025 at Bio Key International, down from $10.5 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $21.5 million in Q1 2021 to a low of $4.2 million in Q1 2024.
• A 5-year average of $12.0 million and a median of $10.5 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity soared 611.53% in 2021 and tumbled 60.41% in 2023, its largest moves.
• Bio Key International's Liabilities and Shareholders Equity stood at $17.8 million in 2021, then sank by 36.16% to $11.3 million in 2022, then tumbled by 60.18% to $4.5 million in 2023, then jumped by 90.73% to $8.6 million in 2024, then climbed by 17.38% to $10.1 million in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $10.1 million, $10.5 million, and $11.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison